Thomas Catinazzo Net Worth & Insider Trades

Thomas Catinazzo - Chief Financial Officer, Relay Therapeutics, Inc

As of November 1, 2022

What is Thomas Catinazzo's Net Worth?

The current estimated net worth of Relay Therapeutics, Inc's Chief Financial Officer, Thomas Catinazzo, is estimated to be about $4.8M . Thomas Catinazzo owns about 50,676 units of Relay Therapeutics, Inc common stock. In the last 2 years at Relay Therapeutics, Inc, Thomas Catinazzo has sold an estimated value of $4.46M worth.

What is Thomas Catinazzo's Past Insider Trading?

Thomas Catinazzo's largest purchase order was 26,257 units , worth over $108.18K on September 8, 2022. Thomas Catinazzo's largest sale order was 22,500 units , worth over $796.5K on November 16, 2021. In total, Thomas Catinazzo has made about 18 transactions over 2 years of their time at Relay Therapeutics, Inc. Thomas Catinazzo usually trades in September, with the busiest year in 2022. The most recent transaction was a sale order of 1,099 units , worth over $23.67K on November 1, 2022.

Thomas Catinazzo

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Thomas Catinazzo's' Mailing Address?

  • Mailing address is C/o Relay Therapeutics, Inc. 399 Binney Street Cambridge MA 02139 MA

Relay Therapeutics, Inc Executive Compensation

Name
Year
Salary
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Sanjiv K. Patel, M.D. 2020 $585,000 $7,965,341 $402,188 - $8,952,529
Sanjiv K. Patel, M.D. 2019 $585,000 $2,590,671 $353,925 - $3,529,596
Donald Bergstrom M.D., Ph.D. 2020 $440,000 $1,339,104 $220,000 $9,816 $2,008,920
Donald Bergstrom M.D., Ph.D. 2019 $406,850 $330,652 $179,014 - $916,516
Brian R. Adams 2020 $390,000 $714,193 $170,625 $7,428 $1,282,246
Brian R. Adams 2019 $356,213 $165,326 $97,958 - $619,497
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1812364/000156459021018016/rlay-def14a_20210519.htm

What are Relay Therapeutics, Inc's Past Insider Trades?

Relay Therapeutics, Inc's most recent insider trade came on November 10, 2022 by Sanjiv Patel who sold 42,000 units worth $842.52K . In the last 2 years, insiders at Relay Therapeutics, Inc have sold an estimated value of $247.98M and bought an estimated value of $4.64M worth of shares. Insider trading is most common in July, with the busiest year in 2022. The most active traders at the company are Donald Bergstrom, President,  Brian Adams, Chief Legal Officer,  and Thomas Catinazzo, Chief Financial Officer .

Relay Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1